Witkowski Adam, Jastrzebski Jan, Dabrowski Maciej, Chmielak Zbigniew
Interventional Cardiology and Angiology Department, Institute of Cardiology, Warsaw, Poland.
J Interv Cardiol. 2014 Jun;27(3):300-7. doi: 10.1111/joic.12120. Epub 2014 Apr 15.
To systematically review reported cases of second transcatheter aortic valve deployment within a previously implanted prosthesis (TAV-in-TAV).
TAV-in-TAV deployment is one of the rescue strategies undertaken due to an unsuccessful or suboptimal transcatheter aortic valve implantation (TAVI) result. Currently, there are no clear indications for second valve implantation and outcomes of patients with 2 prostheses deployed remain poorly known.
The MEDLINE and PubMed databases were searched for cases of TAV-in-TAV implantations of aortic valve.
Forty-three articles reporting on TAV-in-TAV deployment were included in the review. The most frequently observed indication for second valve implantation was aortic regurgitation (AR) occurring shortly after TAVI. There was a strong dominance of paravalvular over intravalvular AR, with prosthesis malposition being the main underlying cause of TAVI failure (81% of all identified cases). Perioperative echocardiographic images are crucial in identifying causes of failure and helpful in optimal rescue strategy selection. Success rate of TAV-in-TAV implantation varies from 90% to 100% with mortality rate of 0-14.3% at 30 days. Despite similar aortic valve function in follow-up, TAV-in-TAV may be an independent predictor of increased cardiovascular mortality.
TAV-in-TAV implantation is feasible and results in favorable short- and mid-term outcomes in patients with acute failure of TAVI without recourse to open-heart surgery. Further studies are needed to establish algorithm of the management of unsuccessful or suboptimal implantation results.
系统回顾已报道的在先前植入的人工心脏瓣膜内进行二次经导管主动脉瓣植入术(瓣中瓣)的病例。
瓣中瓣植入术是因经导管主动脉瓣植入术(TAVI)结果不成功或不理想而采取的挽救策略之一。目前,二次瓣膜植入尚无明确指征,且植入两个人工瓣膜的患者的预后仍知之甚少。
在MEDLINE和PubMed数据库中检索主动脉瓣瓣中瓣植入术的病例。
该综述纳入了43篇关于瓣中瓣植入术的文章。二次瓣膜植入最常见的指征是TAVI后不久出现的主动脉瓣反流(AR)。瓣周漏导致的AR明显多于瓣内漏,人工瓣膜位置不当是TAVI失败的主要潜在原因(在所有已识别病例中占81%)。围手术期超声心动图图像对于确定失败原因至关重要,有助于选择最佳的挽救策略。瓣中瓣植入术的成功率在90%至100%之间,30天死亡率为0至14.3%。尽管随访时主动脉瓣功能相似,但瓣中瓣可能是心血管死亡率增加的独立预测因素。
瓣中瓣植入术是可行的,对于TAVI急性失败且无需进行心脏直视手术的患者,可产生良好的短期和中期预后。需要进一步研究以建立处理不成功或不理想植入结果的算法。